Arthritis and Rheumatology Immunology

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study

Jose U. Scher, Iain B. McInnes, Enrique R. Soriano, Joseph F. Merola, Paul Bird, Vinod Chandran, Edaire Cheng, Elena Reynoso, Warner Chen, Maoji Li, Lianne S. Gensler, Philip J. Mease, Christopher T. Ritchlin
Wiley · 2026-10-27 · DOI 10.1002/art.70152
⬢ Cited by: 2 Crossref

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →